HR-3528-115
Placed on the Union Calendar, Calendar No. 582.
Sponsored by Katherine Clark (D-MA)
What it does
This bill would require prescribers to submit prescriptions electronically — rather than on paper or by phone — for controlled substances covered under Medicare Part D (the prescription drug benefit). It would apply broadly, with certain specified exceptions for situations where electronic prescribing is not feasible or practical.
Who benefits
Medicare Part D enrollees who receive controlled substance prescriptions, who would gain a more secure and trackable prescribing process. Pharmacies that already use electronic systems would face less paperwork. Federal and state drug enforcement agencies would gain better data to detect prescription fraud, "doctor shopping," and diversion of controlled substances. Health IT vendors providing e-prescribing software and infrastructure would see increased demand for their products.
Who is hurt
Prescribers — particularly small, rural, or solo practices — who lack the technology infrastructure or broadband access needed to comply, and who could face compliance costs or penalties. Patients in areas with limited pharmacy or provider technology access could face delays in receiving controlled substance prescriptions. Older or less tech-savvy physicians may face a steeper adjustment burden. Providers who qualify for exceptions may still face administrative complexity in documenting those exceptions.
Supporters argue
Supporters argue that electronic prescribing for controlled substances is a proven tool for reducing prescription drug fraud, forgery, and diversion. Paper prescriptions can be altered, stolen, or counterfeited, while electronic systems create a verified, auditable record that makes it significantly harder to abuse the system. Because Medicare Part D covers tens of millions of beneficiaries and pays for a large share of controlled substance prescriptions, applying this requirement to Medicare would have an outsized effect on reducing misuse. Several states have already enacted similar mandates and have reported reductions in fraudulent prescriptions, suggesting the policy is workable at scale. Supporters also contend that e-prescribing reduces errors caused by illegible handwriting, streamlines the dispensing process for pharmacies, and ultimately improves patient safety.
Opponents argue
Opponents argue that a federal mandate imposes a one-size-fits-all requirement that fails to account for the wide variation in technological readiness among prescribers, particularly those in rural or underserved areas with limited broadband access or smaller operating budgets. Compliance costs — including software, hardware, training, and ongoing maintenance — could be prohibitive for small or independent practices, potentially driving them out of the Medicare program and reducing patient access to care. Critics also contend that the exceptions built into the bill may be narrowly defined, leaving some legitimate prescribers without a workable path to compliance. Additionally, opponents note that electronic systems are not immune to their own security vulnerabilities, including hacking and credential theft, meaning the security benefits may be overstated relative to the burdens imposed.